Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, AlzeCure Pharma AB increased its cash reserves by 13.77%, or 3.52m. The company earned 3.06m from its operations for a Cash Flow Margin of --. In addition the company generated 7.00k and 459.00k cash from investing and financing, respectively.
Cash flow per share | -0.5306 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4625 |
---|---|
Tangible book value per share | 0.4623 |
More ▼
Balance sheet in SEKView more
Current ratio | 5.97 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼